Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer.
Jóhannesson V, Gunnlaugsson A, Nilsson P, Brynolfsson P, Kjellén E, Wieslander E. Jóhannesson V, et al. Among authors: wieslander e. Tech Innov Patient Support Radiat Oncol. 2023 Dec 14;29:100231. doi: 10.1016/j.tipsro.2023.100231. eCollection 2024 Mar. Tech Innov Patient Support Radiat Oncol. 2023. PMID: 38192583 Free PMC article.
Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer.
Rasmusson E, Gunnlaugsson A, Wieslander E, Höglund P, Widmark A, Fransson P, Kjellén E, Nilsson P. Rasmusson E, et al. Among authors: wieslander e. Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):143-151. doi: 10.1016/j.ijrobp.2020.01.022. Epub 2020 Jan 28. Int J Radiat Oncol Biol Phys. 2020. PMID: 32004582 Clinical Trial.
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial.
Killander F, Wieslander E, Karlsson P, Holmberg E, Lundstedt D, Holmberg L, Werner L, Koul S, Haghanegi M, Kjellen E, Nilsson P, Malmström P. Killander F, et al. Among authors: wieslander e. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):701-709. doi: 10.1016/j.ijrobp.2020.04.003. Epub 2020 Apr 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32302682
Initial experience with introducing national guidelines for CT- and MRI-based delineation of organs at risk in radiotherapy.
Olsson C, Nyholm T, Wieslander E, Onjukka E, Gunnlaugsson A, Reizenstein J, Johnsson S, Kristensen I, Skönevik J, Karlsson M, Isacsson U, Flejmer A, Abel E, Nordström F, Nyström L, Bergfeldt K, Zackrisson B, Valdman A. Olsson C, et al. Among authors: wieslander e. Phys Imaging Radiat Oncol. 2019 Sep 23;11:88-91. doi: 10.1016/j.phro.2019.08.006. eCollection 2019 Jul. Phys Imaging Radiat Oncol. 2019. PMID: 33458285 Free PMC article.
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer.
Jóhannesson V, Wieslander E, Nilsson P, Brun E, Bitzén U, Ahlgren G, Olsson T, Bäck S, Kjellén E, Gunnlaugsson A. Jóhannesson V, et al. Among authors: wieslander e. Phys Imaging Radiat Oncol. 2021 Mar 26;18:5-10. doi: 10.1016/j.phro.2021.03.001. eCollection 2021 Apr. Phys Imaging Radiat Oncol. 2021. PMID: 34258401 Free PMC article.
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial.
Gunnlaugsson A, Johannesson V, Wieslander E, Brun E, Bitzen U, Ståhl O, Bratt O, Ahlgren G, Ohlsson T, Kjellén E, Nilsson P. Gunnlaugsson A, et al. Among authors: wieslander e. Clin Transl Radiat Oncol. 2022 Jul 5;36:77-82. doi: 10.1016/j.ctro.2022.07.001. eCollection 2022 Sep. Clin Transl Radiat Oncol. 2022. PMID: 35873652 Free PMC article.
Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial.
Alkner S, de Boniface J, Lundstedt D, Mjaaland I, Ryden L, Vikstrom J, Bendahl PO, Holmberg E, Sackey H, Wieslander E, Karlsson P. Alkner S, et al. Among authors: wieslander e. BMJ Open. 2023 Sep 26;13(9):e075543. doi: 10.1136/bmjopen-2023-075543. BMJ Open. 2023. PMID: 37751948 Free PMC article.
62 results